Pliant Therapeutics Inc (PLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 21,772 | 23,577 | 28,269 | 45,592 | 58,935 |
| Operating Income | -21,772 | -23,577 | -28,269 | -45,592 | -58,935 |
| Interest Expense | 0 | 136 | 815 | 809 | 799 |
| Other Income | 1,732 | 136 | 2,783 | 3,101 | 3,568 |
| Pre-tax Income | -20,040 | -23,577 | -26,301 | -43,300 | -56,166 |
| Net Income Continuous | -20,040 | -23,577 | -26,301 | -43,300 | -56,166 |
| Net Income | $-20,040 | $-23,577 | $-26,301 | $-43,300 | $-56,166 |
| EPS Basic Total Ops | -0.32 | -0.37 | -0.43 | -0.71 | -0.92 |
| EPS Basic Continuous Ops | -0.32 | -0.38 | -0.43 | -0.71 | -0.92 |
| EPS Diluted Total Ops | -0.32 | -0.37 | -0.43 | -0.71 | -0.92 |
| EPS Diluted Continuous Ops | -0.32 | -0.38 | -0.43 | -0.71 | -0.92 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.35 | -0.43 | -0.71 | -0.92 |
| EBITDA(a) | $-21,091 | $-22,930 | $-27,498 | $-43,168 | $-57,125 |